ClearPoint Neuro, Inc.
CLPT
$17.93
-$0.06-0.31%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -29.07M | -25.54M | -23.14M | -22.22M | -20.79M |
| Total Depreciation and Amortization | 2.62M | 2.14M | 1.86M | 1.93M | 1.76M |
| Total Amortization of Deferred Charges | 521.00K | 182.00K | 60.00K | 43.00K | 36.00K |
| Total Other Non-Cash Items | 9.63M | 9.11M | 8.82M | 8.38M | 7.38M |
| Change in Net Operating Assets | -9.43M | -9.81M | -685.00K | 704.00K | 335.00K |
| Cash from Operations | -25.72M | -23.93M | -13.09M | -11.17M | -11.28M |
| Capital Expenditure | -984.00K | -522.00K | -736.00K | -549.00K | -458.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 1.14M | 1.14M | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 153.00K | 615.00K | -736.00K | -549.00K | -458.00K |
| Total Debt Issued | 48.09M | 48.09M | 28.65M | 28.65M | -- |
| Total Debt Repaid | -- | -- | 0.00 | -10.00M | -10.00M |
| Issuance of Common Stock | 4.08M | 3.95M | 3.74M | 3.74M | 430.00K |
| Repurchase of Common Stock | -2.54M | -1.86M | -1.75M | -1.81M | -1.58M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 78.00K | 0.00 | 0.00 | 0.00 | -78.00K |
| Cash from Financing | 49.70M | 50.18M | 30.65M | 20.59M | -11.23M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 24.13M | 26.87M | 16.83M | 8.88M | -22.97M |